Mineralys Therapeutics (MLYS) Current Assets (2022 - 2026)
Mineralys Therapeutics' Current Assets was $665.8 million in Q2 2026, up 98.6% from $335.27 million a year earlier and up 2.0% from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Mineralys Therapeutics came in at $661.39 million, up 222.1% from FY2024.
- Current Assets shows a three-year compound annual growth rate of 80.3% (FY2022 to FY2025).
- In earlier years, Current Assets was $205.35 million in FY2024 (-17.6%), $249.1 million in FY2023 (+120.8%) and $112.81 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Current Assets in data going back to Q4 2022.
- Compared with a year earlier, Current Assets has increased for six straight quarters, with growth averaging 65.0% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q4 2025 (growth of 222.1%); the worst was Q4 2024 (a decline of 17.6%).
- Per Business Quant data, MLYS's Current Assets in the three quarters before Q2 2026 was $652.47 million (Q1 2026), $661.39 million (Q4 2025) and $599.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Mineralys Therapeutics | 2.26 Bn | 2.26 Bn | - | 665.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 665.80 Mn |
| Mar 31, 2026 | 652.47 Mn |
| Dec 31, 2025 | 661.39 Mn |
| Sep 30, 2025 | 599.80 Mn |
| Jun 30, 2025 | 335.27 Mn |
| Mar 31, 2025 | 354.51 Mn |
| Dec 31, 2024 | 205.35 Mn |
| Sep 30, 2024 | 267.73 Mn |
| Jun 30, 2024 | 318.00 Mn |
| Mar 31, 2024 | 346.82 Mn |
| Dec 31, 2023 | 249.10 Mn |
| Sep 30, 2023 | 265.38 Mn |
| Jun 30, 2023 | 269.49 Mn |
| Mar 31, 2023 | 275.27 Mn |
| Dec 31, 2022 | 112.81 Mn |
API Access
Mineralys Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();